This article reviewed the therapeutic use of chitosan as artificial lacrima, medical viscoelastic material, carrier of drug delivery systems and so on in ophthalmic disease.
本文就壳聚糖作为人工泪液、医用粘弹剂、药物缓释系统载体、抗纤维增生药物等的应用进行要的介绍。
This article reviewed the therapeutic use of chitosan as artificial lacrima, medical viscoelastic material, carrier of drug delivery systems and so on in ophthalmic disease.
本文就壳聚糖作为人工泪液、医用粘弹剂、药物缓释系统载体、抗纤维增生药物等的应用进行要的介绍。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的;
发现问题,欢迎向我们指正。
This article reviewed the therapeutic use of chitosan as artificial lacrima, medical viscoelastic material, carrier of drug delivery systems and so on in ophthalmic disease.
本文就壳聚糖作为人工泪液、医用粘弹剂、药物缓释系、抗纤维增生药物等的应用进行
要的介绍。
声明:以上例句、词性分互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
This article reviewed the therapeutic use of chitosan as artificial lacrima, medical viscoelastic material, carrier of drug delivery systems and so on in ophthalmic disease.
本文就壳聚糖作为人、医用粘弹剂、药物缓释系统载体、抗纤维增生药物等的应用进行
要的介绍。
声明:以上例句、词性类均由互联网资源自动生成,部
过人
审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
This article reviewed the therapeutic use of chitosan as artificial lacrima, medical viscoelastic material, carrier of drug delivery systems and so on in ophthalmic disease.
本文就作为人工泪液、医用粘弹剂、药物缓释系统载体、抗纤维增生药物等的应用进行
要的介绍。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工,
表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
This article reviewed the therapeutic use of chitosan as artificial lacrima, medical viscoelastic material, carrier of drug delivery systems and so on in ophthalmic disease.
本文就壳聚糖作为人工泪液、医用粘弹剂、药物统载体、抗纤维增生药物等的应用进行
要的介绍。
声明:以上例句、词性分类均由资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
This article reviewed the therapeutic use of chitosan as artificial lacrima, medical viscoelastic material, carrier of drug delivery systems and so on in ophthalmic disease.
本文就壳聚糖作为人工泪液、医用粘弹剂、药物缓释体、抗纤维增生药物等的应用进行
要的介绍。
声明:以上例句、词性分类联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
This article reviewed the therapeutic use of chitosan as artificial lacrima, medical viscoelastic material, carrier of drug delivery systems and so on in ophthalmic disease.
本文就壳聚糖作为人工泪液、医用粘弹剂、药物缓释系统载体、抗纤维增生药物等的应用进行要的介绍。
声明:以上、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容
表本软件的观点;若发现问题,欢迎向我们指正。
This article reviewed the therapeutic use of chitosan as artificial lacrima, medical viscoelastic material, carrier of drug delivery systems and so on in ophthalmic disease.
本文就壳聚糖作为人工泪液、医用粘、
物缓释系统载体、抗纤维增生
物等的应用进行
要的介绍。
声明:以上例句、词性分类均由互联网资生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
This article reviewed the therapeutic use of chitosan as artificial lacrima, medical viscoelastic material, carrier of drug delivery systems and so on in ophthalmic disease.
本文就壳聚糖作为人工泪液、医用粘弹剂、药物缓释系统载体、增生药物等的应用进行
要的介绍。
声明:以上例句、词类均由互联网资源自动生成,部
未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
This article reviewed the therapeutic use of chitosan as artificial lacrima, medical viscoelastic material, carrier of drug delivery systems and so on in ophthalmic disease.
本文就壳聚糖作为人工泪液、医用粘弹剂、药物缓释系统载体、抗纤药物等的应用进行
要的介绍。
声明:以上、词性分类均由互联网资源自动
成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。